Auricular Stimulation for Relief of Stress and Anxiety During COVID-19 Epidemic (AA_COVID_19)

June 8, 2026 updated by: University Medicine Greifswald

Auricular Stimulation (AS) vs. "Waiting List" for Relief of Stress and Anxiety in Health Care Workers During COVID-19 Pandemic - a Prospective Controlled Investigation

The aim of the study is to evaluate whether auricular stimulation (percutaneous sensory stimulation of cranial nerves) as compared vs. no intervention (waiting list) reduces stress and anxiety in health care providers, working at the time of COVID-19 pandemic at the University Medicine of Greifswald.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Greifswald, Germany, 17475
        • University Medicine of Greifswald

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Medical care workers at the University Medicine of Greifswald
  2. Experiencing stress and anxiety in connection with COVID-19 pandemic
  3. Participants without previous anxiolytic medication
  4. Ability to understand and fill in the structured questionnaire (Appendix D & E)
  5. Written informed consent

Exclusion Criteria:

  1. Recidivist alcoholics
  2. Local auricular skin infection
  3. Pregnant or lactating women
  4. Participants with prosthetic or damaged cardiac valves and mitral valve prolaps (risk of bacterial endocarditis according to guidelines of AHA)
  5. Participants who are unable to understand the consent form
  6. History of psychiatric disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
This group is constituted from patients who will receive the intervention first within 15 weeks
Auricular "acupuncture-like" stimulation (percutaneous sensory stimulation of cranial nerves)
No Intervention: Waiting list
This group is constituted from patients who will receive the intervention after 15 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety
Time Frame: 15 weeks of investigation
State anxiety
15 weeks of investigation

Secondary Outcome Measures

Outcome Measure
Time Frame
Trait anxiety
Time Frame: Before and after 15 weeks of intervention application
Before and after 15 weeks of intervention application
Sleep quality
Time Frame: 15 weeks of investigation
15 weeks of investigation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 3, 2020

Primary Completion (Actual)

August 30, 2021

Study Completion (Actual)

August 30, 2021

Study Registration Dates

First Submitted

January 8, 2021

First Submitted That Met QC Criteria

January 8, 2021

First Posted (Actual)

January 11, 2021

Study Record Updates

Last Update Posted (Actual)

June 11, 2026

Last Update Submitted That Met QC Criteria

June 8, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BB 324/20 (Other Identifier: Ethics Commission of the University Medicine of Greifswald)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress and Anxiety

Clinical Trials on Auricular stimulation

3
Subscribe